ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,622, issued on July 15, was assigned to UNIVERSITA DEGLI STUDI DI FIRENZE (Florence, Italy).
"Pharmaceutical composition of S1PR modulators" was invented by Elisabetta Meacci (Florence, Italy) and Federica Pierucci (Pistoia, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition useful in the prevention and treatment of atrophy or of degeneration of skeletal muscle caused by pathologies or of sarcopenia. The composition includes a combination of molecules that are modulators of the sphingosine-1-phosphate receptors S1PR and one or more pharmaceutically acceptable excipients and/or carriers....